Adam Kern | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Adam Kern | Medicine and Dentistry | Best Researcher Award

University of Warmia and Mazury | Poland

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Adam Kern’s journey into medicine began with his M.D. from the Medical University in Gdańsk in 1995, followed by a Ph.D. from the Medical University of Poznań in 2005. In 2019, he achieved the title of Associate Professor from the University of Warmia and Mazury, where his academic and clinical pursuits have continued to flourish. His early dedication laid a strong foundation for his future contributions in cardiology.

🏥 Professional Endeavors

Dr. Kern currently serves as an Associate Professor in the Department of Cardiology and Internal Medicine at the University of Warmia and Mazury, and as Head of the Cardiac Catheterization Laboratory at Voivodal Specialist Hospital in Olsztyn, Poland. With a career spanning over two decades, he has held various positions from Resident to Senior Assistant and now leads invasive cardiology in both academic and clinical settings. He has overseen over 10,000 coronary angiograms and 5,000 PCIs, marking his role as one of the country’s most experienced interventional cardiologists.

🔬 Contributions and Research Focus

Dr. Kern's research focuses on interventional cardiology, coronary artery bifurcation lesions, and electrotherapy. He has led or contributed to key clinical trials including TRITON TIMI-38, TWILIGHT, POLBOS LM, and PLATO. His doctoral and habilitation work tackled critical aspects of ST-segment elevation ACS and distal left main stem coronary lesions, contributing valuable insights to clinical cardiology.

📚 Scientific Achievements

With 116 published articles, including 54 in Impact Factor journals, Dr. Kern’s academic work has a cumulative impact factor of 150.407 and H-index of 9. His work has been cited 316 times, affirming his role as a respected contributor in cardiovascular medicine. He regularly presents at national and international cardiology conferences, sharing case studies, complication management insights, and advanced techniques.

👨‍🏫 Teaching and Mentorship

Dr. Kern is a passionate educator, training medical students, junior doctors, and interventional cardiologists in pacemaker implantation, angiography, and PCI. His leadership extends to organizing annual country-wide cardiology workshops in Olsztyn and delivering over 10 lectures a year to regional consultants and general practitioners.

🏆 Accolades and Recognition

Dr. Kern’s exceptional service has earned him numerous honors, including:

  • ➤"Best of the Best" Laurel by the Marshal of Warmia and Mazury (2017)

  • ➤Individual Scientific Award from the Rector of UWM (2019)

  • ➤"Meritorious Medical Doctor of Warmia and Mazury" (2020)

  • ➤"Icon of Olsztyn Medicine" (2022)
    These accolades recognize both his scientific merit and his influence in promoting regional healthcare excellence.

🌍 Impact and Influence

As a Fellow of the European Society of Cardiology (FESC) and an active member of EHRA and EAPCI, Dr. Kern's influence reaches beyond Poland. His leadership in structuring primary PCI programs, purchasing and selecting interventional equipment, and mentoring new cardiologists has shaped the cardiology landscape in Warmia and Mazury.

🔮 Legacy and Future Contributions

Dr. Adam Kern continues to build a legacy of clinical precision, academic excellence, and community leadership. His deep involvement in research, combined with a hands-on role in saving lives through interventional procedures, ensures his future contributions will continue to elevate cardiovascular care both nationally and internationally. His leadership in teaching and innovation makes him a guiding force for future cardiologists.

Publications


📄 Kynurenine as a Predictor of Long-Term Mortality: A 10-Year Follow-Up from the KORONEF Registry
Journal: Biomedicines
Year: 2025
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.


📄 Fractal Laws for Bifurcation Quantitative Coronary Angiography to Assess Left Main Bifurcation Lesions
Journal: Cardiology Research and Practice
Year: 2025 
Authors: Mattia Lunardi, Nozomi Kotoku, Carlo Briguori, Luc Maillard, Adam Kern, Franck Digne, Jacek Legutko, Maciej Lesiak, Adam Witkowski, Thierry Lefèvre, et al.


📄 Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics—Insights from the KORONEF Registry
Journal: Biomedicines
Year: 2024
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.


📄 Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results
Journal: Journal of Cardiovascular Development and Disease
Year: 2024
Authors: Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J. Gil


Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

 

Publications


  • 📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
    Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
    Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2023

  • 📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
    Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
    Journal: Journal of Clinical Medicine
    Year: 2022